126 related articles for article (PubMed ID: 8215293)
1. In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin.
McGrath BJ; Marchbanks CR; Gilbert D; Dudley MN
Antimicrob Agents Chemother; 1993 Aug; 37(8):1723-5. PubMed ID: 8215293
[TBL] [Abstract][Full Text] [Related]
2. Emergence of quinolone-imipenem cross-resistance in Pseudomonas aeruginosa after fluoroquinolone therapy.
Aubert G; Pozzetto B; Dorche G
J Antimicrob Chemother; 1992 Mar; 29(3):307-12. PubMed ID: 1317371
[TBL] [Abstract][Full Text] [Related]
3. The influence of postantibiotic effects and postantibiotic effects of sub-inhibitory concentrations of quinolones and aminoglycosides on phospholipase C of Pseudomonas aeruginosa.
Hybenová D; Majtán V
Pharmazie; 1997 Feb; 52(2):157-9. PubMed ID: 9122276
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of bacterial DNA synthesis during postantibiotic effect.
Gottfredsson M; Erlendsdóttir H; Gudmundsson A; Gudmundsson S
Antimicrob Agents Chemother; 1995 Jun; 39(6):1314-9. PubMed ID: 7574522
[TBL] [Abstract][Full Text] [Related]
5. Development of quinolone-imipenem cross resistance in Pseudomonas aeruginosa during exposure to ciprofloxacin.
Rådberg G; Nilsson LE; Svensson S
Antimicrob Agents Chemother; 1990 Nov; 34(11):2142-7. PubMed ID: 2127345
[TBL] [Abstract][Full Text] [Related]
6. In vitro postantibiotic effect of imipenem and enoxacin alone and in combination against Pseudomonas aeruginosa.
Hostacká A
Pharmazie; 1997 Jul; 52(7):544-6. PubMed ID: 9266592
[TBL] [Abstract][Full Text] [Related]
7. Postantibiotic effect of trovafloxacin on Pseudomonas aeruginosa.
Boswell FJ; Andrews JM; Wise R
J Antimicrob Chemother; 1997 Jun; 39(6):811-4. PubMed ID: 9222052
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the bactericidal activity of temafloxacin.
Jacobs MR
Am J Med; 1991 Dec; 91(6A):31S-34S. PubMed ID: 1662893
[TBL] [Abstract][Full Text] [Related]
9. Isolation and in-vitro and in-vivo characterisation of a mutant of Pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem.
Majcherczyk PA; Kunz S; Hattenberger M; Vaxelaire J; Zak O; O'Reilly T
J Antimicrob Chemother; 1994 Oct; 34(4):485-505. PubMed ID: 7646646
[TBL] [Abstract][Full Text] [Related]
10. Temafloxacin: in vitro comparison with five other antibacterial agents.
Digranes A; Hardardottir H; Bottolfsen KL
Chemotherapy; 1991; 37(2):98-105. PubMed ID: 2032475
[TBL] [Abstract][Full Text] [Related]
11. Impact of pharmacokinetics on the postantibiotic effect exhibited by Pseudomonas aeruginosa following tobramycin exposure: application of an in-vitro model.
Zhu ZY; Li RC
J Antimicrob Chemother; 1998 Jul; 42(1):61-5. PubMed ID: 9700529
[TBL] [Abstract][Full Text] [Related]
12. Postantibiotic effect of DU-6859a and levofloxacin as compared with ofloxacin.
Houston AK; Jones RN
Diagn Microbiol Infect Dis; 1994 Jan; 18(1):57-9. PubMed ID: 8026158
[TBL] [Abstract][Full Text] [Related]
13. Postantibiotic and bactericidal effect of imipenem against Pseudomonas aeruginosa.
Odenholt I; Isaksson B; Nilsson L; Cars O
Eur J Clin Microbiol Infect Dis; 1989 Feb; 8(2):136-41. PubMed ID: 2498095
[TBL] [Abstract][Full Text] [Related]
14. Post-antibiotic effect of ceftazidime, ciprofloxacin, imipenem, piperacillin and tobramycin for Pseudomonas cepacia.
Kumar A; Hay MB; Maier GA; Dyke JW
J Antimicrob Chemother; 1992 Nov; 30(5):597-602. PubMed ID: 1283606
[TBL] [Abstract][Full Text] [Related]
15. The postantibiotic effect of meropenem and imipenem on selected bacteria.
Nadler HL; Pitkin DH; Sheikh W
J Antimicrob Chemother; 1989 Sep; 24 Suppl A():225-31. PubMed ID: 2509416
[TBL] [Abstract][Full Text] [Related]
16. [The activity of four fluoroquinolones against strains of Pseudomonas aeruginosa with a different sensitivity pattern to ceftazidime and imipenem].
Pascual A A; Joyanes P; Martínez-Martínez L; del Carmen Conejo M; Hernández G; Chaves J; Perea EJ
Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):432-4. PubMed ID: 11709121
[TBL] [Abstract][Full Text] [Related]
17. Aminoglycoside Concentrations Required for Synergy with Carbapenems against Pseudomonas aeruginosa Determined via Mechanistic Studies and Modeling.
Yadav R; Bulitta JB; Schneider EK; Shin BS; Velkov T; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28893782
[TBL] [Abstract][Full Text] [Related]
18. Influence of the postantibiotic effect and postantibiotic sub-MICs effect of netilmicin, tobramycin, ciprofloxacin and pefloxacin on alginate production by Pseudomonas aeruginosa.
Majtán V; Hostacká A
Folia Microbiol (Praha); 1996; 41(3):228-32. PubMed ID: 9449771
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms and frequency of resistance to temafloxacin.
Appelbaum PC
Am J Med; 1991 Dec; 91(6A):27S-30S. PubMed ID: 1662892
[TBL] [Abstract][Full Text] [Related]
20. In-vitro postantibiotic effect of sparfloxacin and ciprofloxacin against Pseudomonas aeruginosa and Enterococcus faecalis.
Pastor A; Pemán J; Cantón E
J Antimicrob Chemother; 1994 Nov; 34(5):679-85. PubMed ID: 7706163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
